Valuation Morepen Laboratories Limited NSE India S.E.

Stocks

Market Closed - NSE India S.E. Other stock markets 14:05:08 01/07/2026 +03			5-day change	1st Jan Change
62.68 ^INR	+6.02%		+19.85%	+52.62%

05-26	Morepen Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
05-26	Morepen Laboratories Limited Recommends Final Dividend for the Year Ended 31 March, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2020	2021	2022	2023	2024	2025
Market Cap ¹	4,291	14,462	17,488	13,127	21,500	26,220
Change	-	237%	20.93%	-24.94%	63.79%	21.95%
Enterprise Value (EV) ¹	5,486	15,415	18,663	13,162	21,620	26,219
Change	-	180.98%	21.07%	-29.48%	64.27%	21.27%
P/E	12.8x	15x	18.7x	33.4x	22.4x	21.8x
PBR	1.51x	3.4x	3.02x	1.74x	2.54x	2.27x
PEG	-	0x	-2.12x	-0.6x	0x	1.3x
Capitalization / Revenue	0.5x	1.21x	1.12x	0.92x	1.26x	1.45x
EV / Revenue	0.64x	1.29x	1.2x	0.93x	1.27x	1.45x
EV / EBITDA	8.19x	12.5x	13.9x	19.2x	14x	16.2x
EV / EBIT	14.9x	15.7x	15.8x	23.5x	15.8x	18.1x
EV / FCF	-31.9x	-54.9x	-13x	-47.9x	-94x	-11.8x
FCF Yield	-3.13%	-1.82%	-7.71%	-2.09%	-1.06%	-8.51%
Dividend per Share ²	-	-	-	-	-	0.2
Rate of return	-	-	-	-	-	0.42%
EPS ²	0.7465	2.15	1.96	0.77	1.88	2.2
Distribution rate	-	-	-	-	-	9.09%
Net sales ¹	8,584	11,980	15,558	14,220	17,019	18,116
EBITDA ¹	670.3	1,230	1,338	686.6	1,545	1,620
EBIT ¹	369	981.7	1,180	560.8	1,366	1,451
Net income ¹	335.8	970.9	1,017	386.8	961.6	1,180
Net Debt ¹	1,195	953.1	1,174	34.98	120.5	-0.928
Reference price ²	9.54	32.15	36.60	25.68	42.06	47.85
Nbr of stocks (in thousands)	449,826	449,826	477,826	511,169	511,169	547,954
Announcement Date	9/5/20 A	9/4/21 A	9/2/22 A	9/4/23 A	8/1/24 A	8/12/25 A

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	35.06x	12.74x	25.95x	0.57%	1,070B
JOHNSON & JOHNSON	27.14x	6.24x	16.98x	2.1%	611B
ABBVIE INC.	31.04x	7.44x	15.22x	2.75%	445B
ROCHE HOLDING AG	17.73x	4.41x	10.84x	3.01%	329B
ASTRAZENECA PLC	23.3x	4.89x	13.84x	1.78%	290B
NOVARTIS AG	21.86x	5.61x	13.55x	2.82%	287B
NOVO NORDISK A/S	13.89x	5.16x	10.6x	3.6%	213B
AMGEN INC.	23.6x	6.28x	11.05x	2.79%	195B
GILEAD SCIENCES, INC.	-45.11x	5.46x	30.35x	2.57%	157B
Average	16.50x	6.47x	16.49x	2.44%	399.58B
Weighted average by Cap.	24.26x	7.90x	18.23x	1.99%